Philadelphia Inquirer, The - Wyeth says heart–drug competition was surprise
THE FDA SAYS development of a potentially life-threatening serotonin syndrome may occur in treatment with four selective serotonin reuptake inhibitors: Lilly’s Cymbalta (duloxetine HCl) delayed release capsules, Wyeth’s Effexor (venlafaxine HCL) tablets and Effexor extended release capsules, Lilly’s Prozac (fluoxetine capsules and oral solution) and Lilly’s Symbyax (olanzapine and fluoxetine HCL capsules).
Most Popular
10 Jobs That Pay $30 An Hour
Eight Major Job Trends For 2008
Five Ways To Successfully Negotiate A Salary
5 Regular Mistakes In Public Speaking
Today’s Best Part-Time Jobs
-JGD
Copyright Haymarket Media, Inc. Dec 2006
Provided by ProQuest Information and Learning Company. All rights Reserved
